Sarclisa

Isatuximab-Irfc

6.0 Moderate risk

Sarclisa & Infusion related reaction

100.0%

of users reported Infusion related reaction

66.7%

also reported Severe reaction

87.5%

are women

Most common medical consequences

Severe reaction
66.7%
Hospitalization
33.3%

Have you experienced any negative side effects from this medication?

Sarclisa: general information

Most common side effects (1)

Most commonly affected ages

70 - 79 years
100.0%